Aromasin - Zyvex Pharmaceuticals

Zyvex Pharmaceuticals
๐Ÿ’Š
Aromasin - Zyvex Pharmaceuticals
Exemestane 20 mg/tab | Zyvex Pharmaceuticals | Steroidal Aromatase Inhibitor
โš™
Class
Steroidal AI
Suicidal inhibitor
โฐ
Half-Life
~27 hours
daily or EOD dosing
๐Ÿ“ˆ
Estrogen Reduction
Up to 85%
at 25 mg/day
๐ŸŽฏ
Use Phase
On-Cycle + PCT
Nolvadex compatible

Standard Dose
12.5 mg EOD
on cycle
Heavy Cycles
25 mg EOD
high test / wet stacks
PCT Dose
12.5-25 mg EOD
with Nolvadex
Half-Life
~27 hours
daily or EOD
Manufacturer Zyvex Pharmaceuticals
Brand Aromasin
Substance Exemestane
Concentration 20 mg/tab
Pack Size 100 tabs
Out of Stock

Aromasin - Zyvex Pharmaceuticals Overview

Aromasin by Zyvex Pharmaceuticals contains Exemestane at 20 mg per tablet - a steroidal, suicidal aromatase inhibitor used during and after anabolic steroid cycles to manage estrogen. Unlike reversible AIs such as Anastrozole (Arimidex), Exemestane permanently inactivates each aromatase enzyme molecule it binds to. New estrogen production is blocked until the body synthesizes new aromatase enzymes, which creates a more stable suppression effect and a smoother recovery when the compound is discontinued.

Aromasin has two distinct roles in a bodybuilding context: on-cycle estrogen control and post-cycle therapy (PCT) support. It is one of the only AIs compatible with Nolvadex in PCT, making it the practical choice for athletes who need both estrogen management and SERM-based HPG axis stimulation during recovery.

Steroidal AI Suicidal Inhibitor Oral Tablet On-Cycle Use PCT Compatible Cycle Support

About the Compound: Exemestane 20 mg

Exemestane is a third-generation steroidal aromatase inhibitor - the only steroidal AI in common use among bodybuilders. Its steroidal structure means it shares a chemical backbone with androgens, which gives it two properties that separate it from non-steroidal AIs like Anastrozole: it permanently deactivates the aromatase enzyme (suicidal inhibition), and it carries a weak androgenic anabolic profile of its own. The androgenic contribution is modest at standard doses, but measurable in some athletes.

Zyvex Pharmaceuticals produces Aromasin at 20 mg per tablet, 100 tablets per pack. The half-life of Exemestane is approximately 27 hours - shorter than Anastrozole's 48 hours. This means daily dosing maintains stable blood levels better than EOD, though EOD at higher doses (25 mg EOD) is also used in practice. At 25 mg/day, Exemestane suppresses estrogen production by up to 85%. The suicidal mechanism means that when you stop taking it, the residual suppression fades gradually as the body produces new aromatase - avoiding the rapid estrogen rebound that can occur when reversible AIs are discontinued abruptly.

Manufacturer
Zyvex Pharmaceuticals
Active Substance
Exemestane
Concentration
20 mg/tab
Pack Size
100 tablets
Half-Life
~27 hours
Mechanism
Suicidal (irreversible) AI
Estrogen Reduction
Up to 85% at 25 mg/day
Use Phase
On-Cycle and PCT
PCT Compatibility
Compatible with Nolvadex

What Aromasin Does

Exemestane manages estrogen during aromatizing steroid cycles and supports post-cycle recovery. Its effects are the same category as other AIs - estrogen control - but the suicidal mechanism and PCT compatibility distinguish it from its main alternative.

  • Estrogen suppression on cycle - blocks aromatase conversion of androgens to estradiol, preventing water retention, gynecomastia risk, and mood instability caused by excess estrogen on testosterone-based cycles. At 12.5-25 mg EOD it provides consistent, well-controlled suppression.
  • Smoother recovery when discontinued - because Exemestane permanently inactivates aromatase enzymes, stopping it does not produce an immediate enzyme reactivation. Estrogen rebuilds gradually over days as new aromatase is synthesized. This prevents the sharp estrogen spikes sometimes seen when reversible AIs like Anastrozole are stopped abruptly.
  • PCT-compatible estrogen management - unlike Anastrozole, Exemestane does not reduce the plasma concentration of Tamoxifen (Nolvadex). The two can be used together in PCT without losing efficacy, allowing simultaneous estrogen control and HPG axis stimulation in the recovery window.
  • Mild anabolic contribution - Exemestane's steroidal structure gives it a slight androgenic anabolic effect. At standard doses this is minor, but some athletes report a marginal hardening effect and slightly better strength retention compared to non-steroidal AIs at equivalent estrogen suppression.

Same rule as all AIs: the goal is estrogen management, not elimination. Suppressing estrogen below the functional range with Aromasin produces the same symptoms as Arimidex overuse - joint pain, low libido, fatigue, and depression. Start at the lower dose and adjust based on symptoms and bloodwork (target estradiol: 20-40 pg/mL on cycle).

Dosing and Timing

Standard On-Cycle Dose

The standard starting dose is 12.5 mg every other day (EOD) for most testosterone cycles in the 300-500 mg/week range. Given the 27-hour half-life, some athletes prefer 12.5 mg daily for more stable blood levels at the cost of higher overall daily dose. Both approaches work - EOD at 12.5 mg is sufficient for most moderate cycles. At 500 mg/week testosterone or with high-aromatizing stacks (Dianabol, Anadrol), increase to 25 mg EOD. The maximum commonly used dose is 25 mg/day, reserved for very heavy cycles with confirmed elevated estradiol on bloodwork.

When to Start Aromasin on Cycle

For long-ester testosterone cycles (Enanthate, Cypionate), start Aromasin in week 2 or 3, when testosterone levels begin rising meaningfully. For short esters (Propionate) or front-loaded cycles, start from day 1. The shorter half-life of Exemestane compared to Anastrozole means it clears faster when you stop - giving slightly more flexibility to time the transition to PCT.

Aromasin in PCT

When PCT requires both estrogen management and SERM-based axis stimulation, Aromasin is the correct AI choice because it does not reduce Nolvadex plasma concentration. The typical PCT protocol with Aromasin: 25 mg EOD alongside Nolvadex 20-40 mg/day, starting at the appropriate post-cycle timing. Some athletes taper Aromasin down to 12.5 mg EOD as PCT progresses and estrogen begins stabilizing naturally. Stop Aromasin before the end of PCT, not at the same time as Nolvadex - let estrogen normalize fully before discontinuing the SERM.

Which Cycles Benefit Most from Aromasin

Cycle Aromatization Level Recommended Aromasin Dose
Testosterone 300-400 mg/wk Moderate. Most men see some estrogen increase. Some individuals aromatize heavily even at this range. 12.5 mg EOD as a starting point. Some men at this dose do not need an AI - confirm with bloodwork before assuming you do.
Testosterone 500 mg/wk High. The majority of athletes running 500 mg test will experience estrogen symptoms without AI support. 12.5-25 mg EOD depending on bloodwork and individual response. Start at 12.5 mg EOD and adjust.
Test + Dianabol / Anadrol Very high. Wet oral compounds add significant aromatase load on top of testosterone. 25 mg EOD or 25 mg daily during the oral portion. Monitor closely - these stacks can drive estrogen very high quickly.
Test + Deca or NPP Moderate. Nandrolone aromatizes modestly. Testosterone drives the main estrogen increase. 12.5-25 mg EOD covering the testosterone base. Progesterone-related sides from Nandrolone are separate and not addressed by Exemestane.
PCT (any prior cycle) Variable. Residual estrogen from the cycle, plus potential rebound as testosterone clears. 25 mg EOD combined with Nolvadex 20-40 mg/day. Aromasin is the preferred AI for PCT because it does not impair Nolvadex efficacy.

Side Effects and Risks

What May Occur Background How to Handle It
Crashed estrogen (low E2) Overuse at 25 mg/day or use on non-aromatizing cycles drives estradiol too low. Symptoms: joint pain and dryness, low libido, erectile dysfunction, fatigue, depression, brain fog. Same risk as with Arimidex, though the smoother recovery curve when stopping Aromasin makes correction slightly easier. Stop Exemestane and allow estrogen to rebuild naturally over 1-2 weeks. The suicidal mechanism means recovery is gradual - avoid restarting at the same dose. Get an estradiol bloodwork panel to confirm before resuming.
Bone density impact Estrogen is essential for bone maintenance in men. Prolonged or aggressive suppression across multiple cycles contributes to reduced bone mineral density over time. Use Aromasin at minimum effective doses, only during cycles. Avoid long-term off-cycle use. Monitor bone health markers if running extended cycles.
HDL reduction Estrogen supports HDL (good cholesterol). Suppressing it with any AI reduces HDL and compounds the lipid impact of the anabolic compounds themselves. Take omega-3 supplementation, run cardio, and keep diet clean during the cycle. Monitor lipids via bloodwork.
Mild androgenic activity Exemestane's steroidal structure gives it a very weak androgenic profile. In sensitive individuals this may contribute slightly to acne or oiliness at higher doses. At 12.5-25 mg EOD this is rarely noticeable. Monitor and reduce dose if skin-related symptoms appear.

Post-Cycle Recovery with Aromasin

Aromasin is the preferred AI for athletes running Nolvadex-based PCT. Unlike Anastrozole, Exemestane does not reduce Tamoxifen's plasma concentration - both compounds retain their full efficacy when run together. This makes Aromasin the practical choice whenever an AI is needed during the recovery window.

Product Role in PCT
Aromasin (Exemestane) Manages estrogen during PCT to prevent rebound gynecomastia and water retention as testosterone clears. Compatible with Nolvadex. Standard dose: 25 mg EOD, tapering to 12.5 mg EOD as PCT progresses. Discontinue before the end of PCT to allow natural estrogen recovery.
Nolvadex (Tamoxifen) SERM that blocks estrogen receptors at the pituitary to stimulate LH and FSH release and restart natural testosterone production. 20-40 mg/day for 4 weeks is standard. Run alongside Aromasin when estrogen control is needed simultaneously.
Clomid (Clomiphene) Added for stronger HPG axis stimulation after heavy suppressive cycles (long cycles, multiple compounds, or high doses). 50 mg/day for the first 2 weeks of PCT alongside Nolvadex. Aromasin can be run concurrently with both SERMs without interaction issues.

Bloodwork at 4-6 weeks post-PCT is the only reliable way to confirm full recovery. If natural testosterone has not returned to baseline, extend the PCT or consult a healthcare provider.

Frequently Asked Questions

  • What is Aromasin and how does it differ from other AIs?

    Aromasin (Exemestane) is a steroidal, suicidal aromatase inhibitor. It works by permanently inactivating the aromatase enzyme it binds to - once Exemestane deactivates an aromatase molecule, that molecule cannot convert androgens to estrogens again. This is the "suicidal" part of the name. In contrast, non-steroidal AIs like Anastrozole (Arimidex) bind reversibly - the enzyme can reactivate when the drug clears. The practical consequence: when you stop Aromasin, estrogen recovers gradually as the body produces new aromatase. When you stop Anastrozole, enzyme activity can return quickly, sometimes producing an estrogen rebound spike. Aromasin's steroidal backbone also gives it a mild androgenic profile - it will not show as a traditional anabolic steroid on testing, but it carries a slight anabolic effect not present in non-steroidal AIs.

  • Can Aromasin be used for bodybuilding?

    Yes - Aromasin is used in bodybuilding specifically as on-cycle estrogen control and as the preferred AI for post-cycle therapy. On anabolic steroid cycles that include testosterone or other aromatizing compounds, the body converts a portion of those androgens into estradiol via the aromatase enzyme. Elevated estrogen causes water retention, gynecomastia, mood swings, and loss of muscle definition. Aromasin blocks this conversion at 12.5-25 mg EOD, keeping estrogen in the functional range for the duration of the cycle. Its second role - PCT support - is where it particularly stands out: it can be combined with Nolvadex without interaction issues, making it the only AI that works cleanly alongside the standard PCT SERM.

  • What is the correct Aromasin dose on a steroid cycle?

    The standard starting dose for on-cycle use is 12.5 mg every other day (EOD) for most testosterone cycles in the 300-500 mg/week range. The 27-hour half-life supports either daily or EOD dosing - 12.5 mg daily gives more stable blood levels but a higher overall daily dose; 12.5 mg EOD is sufficient for most moderate cycles. For heavier cycles at 500 mg/week testosterone or with added aromatizing orals (Dianabol, Anadrol), use 25 mg EOD. The maximum commonly applied dose is 25 mg/day, reserved for very high-aromatizing cycles with confirmed bloodwork. Do not start at the maximum - individual aromatization varies significantly, and overuse crashes estrogen just as effectively as underuse fails to control it.

  • How long does Aromasin take to lower estrogen?

    Exemestane begins suppressing aromatase activity within hours of the first dose. Measurable estrogen reduction occurs within 24 hours. Stable, lower estrogen levels are typically reached within 2-4 days of consistent dosing - slightly faster than Anastrozole in some studies, likely due to the irreversible binding mechanism building cumulative suppression quickly. Existing symptoms like water retention take longer to fully resolve - typically 7-14 days as the body sheds retained fluid. The suicidal mechanism means the suppression deepens over the first several doses as more aromatase enzymes are permanently inactivated. This is also why the dose needs to stay conservative at the start - the effect builds, and starting too high can lead to crashed estrogen by day 5-7 before you realize there is a problem.

  • Aromasin vs Arimidex - which AI is better?

    Both control estrogen effectively on cycle. The deciding factor is how you plan your PCT. If you are running Nolvadex in PCT, Aromasin is the correct choice. Anastrozole (Arimidex) reduces the plasma concentration of Tamoxifen when taken together - the combination is less effective than either alone. Aromasin does not have this interaction. You can run Aromasin and Nolvadex simultaneously in PCT without losing the benefit of either. On-cycle, the practical differences are: Aromasin has a shorter half-life (27h vs 48h for Anastrozole) and is dosed in milligrams that look different on paper - 12.5-25 mg vs Anastrozole's 0.5-1 mg. Both provide similar estrogen suppression at their respective standard doses. Aromasin's suicidal mechanism means stopping it produces a smoother estrogen recovery; stopping Anastrozole abruptly can trigger a faster rebound. For athletes planning standard PCT with Nolvadex, Aromasin is the better-integrated choice.

  • Why is Aromasin preferred for PCT over Arimidex?

    The reason is a specific pharmacokinetic interaction: Anastrozole (Arimidex) reduces the plasma concentration of Tamoxifen (Nolvadex) when taken simultaneously - clinical data shows Tamoxifen levels drop meaningfully when combined with Anastrozole, reducing its efficacy. This makes the combination less effective than Nolvadex alone. Exemestane does not have this interaction - plasma levels of Tamoxifen are not significantly affected by concurrent Aromasin use. The second reason is the recovery profile: Aromasin's suicidal mechanism means estrogen rebuilds gradually after you stop it, which aligns well with PCT - you want estrogen to normalize as the axis recovers, and a smooth rebound is preferable to a sharp spike. The practical recommendation: use whichever AI you prefer on-cycle, but switch to Aromasin (or stop the AI entirely and let estrogen normalize) when you transition to PCT with Nolvadex.

  • Does Aromasin have any anabolic or androgenic properties?

    Yes, mildly. Exemestane's steroidal chemical structure shares similarities with androgens - specifically it is derived from androstenedione. This gives it a very weak androgenic anabolic activity at standard doses. In practice, this contribution is minor: most athletes will not notice a meaningful strength or muscle effect from Exemestane itself at 12.5-25 mg EOD. Some users report a marginally harder physique compared to running Anastrozole at equivalent estrogen suppression, but this is difficult to isolate and may be partly explained by differences in estrogen levels. What it does not do: it does not show on anabolic steroid panels in standard sports drug testing as a traditional anabolic steroid. Its androgenic activity is low enough that it does not drive typical androgenic side effects (acne, hair loss) at standard AI doses in most individuals.

  • What are the signs that Aromasin has crashed my estrogen?

    Crashed estrogen from Aromasin produces the same symptoms as crashed estrogen from any AI overuse: severe joint pain and dryness (knees, shoulders, elbows), complete loss of libido, inability to achieve or maintain erections, depression, emotional flatness, fatigue, poor sleep quality, and brain fog. These symptoms typically appear within 3-7 days of the crash and can persist for 2-4 weeks during recovery. One difference with Aromasin vs Anastrozole: because Exemestane permanently inactivates aromatase, the recovery after stopping it is gradual as the body produces new enzymes. Do not restart Aromasin as soon as you feel better - allow full estrogen normalization before resuming at a lower dose. Get an estradiol bloodwork panel to confirm where you are before making any adjustments.